Streetbeat News

Analyst Ratings

PCH

Truist Securities analyst Michael Roxland has maintained a Hold rating on PotlatchDeltic (NASDAQ:PCH) and increased the price target from $50 to $51.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 3:51 pm

SOFI

SoFi Technologies Inc (NASDAQ:SOFI) shares are trading higher after announcing a 2% match on IRA contributions through Tax Day, doubling its previous 1% match offer. This follows a recent downgrade by Keefe, Bruyette & Woods analyst Michael Perito, who lowered SoFi's rating from Market Perform to Underperform and reduced the price target from $7.50 to $6.50. Despite the downgrade, SoFi shares were up 2.52% at $8.51.

Portfolio Pulse from Adam Eckert

January 04, 2024 | 3:50 pm

RYN

Truist Securities analyst Michael Roxland has maintained a Hold rating on Rayonier (NYSE:RYN) and increased the price target from $33 to $34.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 3:47 pm

ATAI

HC Wainwright & Co. analyst Patrick Trucchio has reiterated a Buy rating on ATAI Life Sciences (NASDAQ:ATAI) and maintained a $20 price target for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 3:46 pm

LAW

Needham analyst Scott Berg has reiterated a Buy rating on CS Disco (NYSE:LAW) and maintained a $15 price target for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 3:43 pm

WRK

Truist Securities analyst Michael Roxland has maintained a Hold rating on WestRock (NYSE:WRK) and increased the price target from $40 to $48.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 3:41 pm

RYTM

Needham analyst Joseph Stringer has reaffirmed a Buy rating on Rhythm Pharmaceuticals (NASDAQ:RYTM) and increased the price target from $45 to $50.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 3:38 pm

RUN

Sunrun Inc.'s stock (RUN) is trading lower following a downgrade by Keybanc from Overweight to Sector Weight.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 3:37 pm

INTC

Tigress Financial analyst Ivan Feinseth has reiterated a Buy rating on Intel Corporation (NASDAQ:INTC) and increased the price target from $46 to $66.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 3:28 pm

RIGL

HC Wainwright & Co. analyst Joseph Pantginis has reiterated a Buy rating on Rigel Pharmaceuticals (NASDAQ:RIGL) and maintained a $15 price target on the stock.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 3:27 pm